TransSerum? FQ Fetal Bovine Serum
胎牛血清 FQ
目錄號： FS301-02
單 價：￥4800
產(chǎn)品詳情介紹
本產(chǎn)品以健康胎牛血液為原料加工而成，經(jīng)3次0.1 μm微孔濾膜過濾，無支原體污染，不含BVDV、BPV等牛源病毒，內(nèi)毒素水平極低。培養(yǎng)細胞種類多，細胞生長速度快，狀態(tài)好，適用于間充質(zhì)干細胞的培養(yǎng)。培養(yǎng)的細胞適用于多種下游實驗。
【廣譜通用型】“夠用不貴”的性價比典范，為多種常見傳代細胞系提供穩(wěn)定可靠的支持。
應(yīng)用范圍
適用于間充質(zhì)干細胞及常見傳代細胞如A549、HeLa、Vero、MDCK等多種細胞的培養(yǎng)。
TransSerum? FQ Fetal Bovine Serum成功培養(yǎng)的細胞
病毒檢測
通過免疫熒光抗體法檢測TransGen FQ血清中的病毒殘留，結(jié)果如下：
支原體檢測
使用全式金支原體檢測試劑盒 TransDetect? PCR Mycoplasma Detection Kit (FM311)對Company B和TransGen FQ血清進行檢測，結(jié)果表明,Company B 和TransGen FQ血清均無支原體污染。
間充質(zhì)干細胞培養(yǎng)圖
配制含TransGen FQ 血清的生長培養(yǎng)基，培養(yǎng)間充質(zhì)干細胞，在顯微鏡下觀察每一代細胞的形態(tài)。
普通細胞培養(yǎng)圖 (部分結(jié)果)
配制含有Company B 和TransGen FQ 血清的生長培養(yǎng)基，培養(yǎng)不同類型的細胞，在顯微鏡下觀察每一代細胞的形態(tài)。
血清介紹視頻
?Shen Y, Wang J, Li Y, et al. Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2[J]. Cell Discovery, 2022.(IF 38.08)
?Wang A, Tian Y, Liu H, et al. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein[J]. Emerging Microbes & Infections, 2022.(IF 19.57)
?Xiang H, Yang J, Cao X, et al. Flexible and highly sensitive triboelectric nanogenerator with magnetic nanocomposites for cultural heritage conservation and human motion monitoring[J]. Nano Energy, 2022.(IF 19.06)
?Wang Z, Chen Z, Zhang Z, et al. Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ[J]. Nano Today, 2022.(IF 18.96)
?Chen K, Zhou R, Liang H, et al. Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement[J]. Nano Today, 2023.(IF 17.40)
?Chen K, Liu S, Lv L, et al. Well-established immunotherapy with R837-loaded boron neutron capture-shocked tumor cells[J]. Nano Today, 2023.(IF 17.40)
?Qin P P, Chen P R, Tan L, et al. Programming ADAR-recruiting hairpin RNA sensor to detect endogenous molecules[J]. Nucleic Acids Research, 2025.(IF 16.70)
?Chen P R, Qin P P, Wang Y N, et al. De novo design of hypercompact transcript degraders by engineering substrate-specific toxins and Cas6-CBS system[J]. Nature Communications, 2025.(IF 15.70)
?Hou P, Zhu H, Chu F, et al. Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-?B[J]. Nature Communications, 2025.(IF 15.70)
?Liang H, Chen K, Xie J, et al. A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication[J]. Small, 2023.(IF 15.15)
?Ma P Q, Huang F W, Xie Y Q, et al. Universal DNA-Based Sensing Toolbox for Programming Cell Functions[J]. Journal of the American Chemical Society, 2023.(IF 15.00)
?Liu H, Fan H, He P, et al. Prohibitin 1 regulates mtDNA release and downstream inflammatory responses[J]. The EMBO Journal, 2022.(IF 14.01)
?Hou P, Wang X, Wang H, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication[J]. Autophagy, 2022.(IF 13.39)
